single product

Generic Sonata

$173.48$668.15

Sonata is a brand name of zaleplon, approved by the FDA in the following formulation(s):

SONATA (zaleplon – capsule;oral)

  • Manufacturer: PFIZER
    Approval date: August 13, 1999
    Strength(s): 5MG, 10MG
Clear
N/A ,

Description

Sleep-wake disorders

Indications for SONATA:

Short-term treatment of insomnia.

Adult:

Usually 10mg at bedtime (at least 4hrs before becoming active again); max 20mg. Mild-to-moderate hepatic impairment, elderly, debilitated, concomitant cimetidine, or low weight patients: 5mg; max 10mg. Max 1month/℞. Effect delayed if taken with high-fat/heavy meals.

Children:

Not established.

Warnings/Precautions:

Severe hepatic impairment: not recommended. Compromised respiratory function, mild-to-moderate hepatic impairment, debilitated: monitor closely. Depression. Behavioral changes. Suicidal tendencies. Drug or alcohol abuse. Conditions that affect metabolism or hemodynamic response. Write ℞ for smallest practical amount. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C), nursing mothers: not recommended.

Pharmacological Class:

Pyrazolopyrimidine hypnotic.

Interactions:

Potentiates CNS depression with alcohol, other CNS depressants. Efficacy may be compromised by drug(s) that induce CYP3A4. May be potentiated by drugs that inhibit aldehyde oxidase (eg, cimetidine, possibly diphenhydramine). May be antagonized by promethazine.

Adverse Reactions:

CNS effects, complex sleep-related behaviors (eg, sleep-driving), GI upset, abdominal pain, migraine; anaphylaxis, angioedema, others (see full labeling).

How Supplied:

Caps—100

Additional information

Quantity

15, 30, 60

WhatsApp chat